Plasticell announces grant of fundamental CombiCult patents in USA and Japan

15-Feb-2012 - United Kingdom

Plasticell announced that patents for its combinatorial cell culture platform technology, CombiCult™, have been granted in the USA and Japan.  Patents covering CombiCult™ have now been issued in Europe, USA, Japan, Australia and Singapore.

“Plasticell's  proprietary technology breaks the major bottleneck in current stem cell research. Having followed CombiCult™'s development for almost a decade, I am delighted that the importance of this revolutionary technology is now being recognised through multiple industry awards and patents”, commented Sir Martin Evans FRS, a founding member of Plasticell’s Scientific Advisory Board and recipient of the Nobel prize for the isolation of embryonic stem cells.

Dennis Saw, CEO of Plasticell added, “Since 2002, Plasticell has continually innovated and expanded intellectual property coverage to secure its leading position in the stem cell space. Granted patents in the USA, Europe and Japan mean that the CombiCult™ process, which underlies many of our technologies, is now protected in all the major biotech markets which we operate in.”

Other news from the department research and development

Most read news

More news from our other portals

Fighting cancer: latest developments and advances